Researchers at 91°µÍø will present eight innovative technologies currently available for commercialization during a public event at ORNL on October 17.
The Department of Energy’s 91°µÍø is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
A novel approach to studying the viscosity of water has revealed new insights about the behavior of water molecules and may open pathways for liquid-based electronics.